Tudigo continues to push a mix of impact, innovation and tax-efficient equity deals:
A new biotech from CEA to big pharma is about to open its round on Tudigo, with 400+ investors pre-registered in 24h and up to 50% tax reduction on the amount invested – positioned as a flagship life-science opportunity for 2025.
Another upcoming off-market prime hypermarket deal in Greater Geneva is attracting heavy interest, with hundreds of investors and strong intention volumes in just hours – a classic “club deal immobilier” designed for income-seeking investors.
Existing campaigns like Velco (connected bike tech) and Julienne (local convenience retail) show strong traction: Velco rapidly hit its minimum €400k target with 160+ investors, while Julienne has raised over €51k from 30 investors alongside store expansion in the Paris region.
Tudigo also showcased Le Rouge Français (clean beauty brand, international expansion) and Blue Bees Therapeutics (immunotherapy biotech), with deadlines approaching and fiscal incentives (up to 18–50% tax reduction) clearly highlighted.
On the platform UX side, Tudigo has redesigned its opportunity pages to make key information (team, technology, business model, risks) easier to navigate – a direct improvement for retail investors comparing deals on the platform.
Sowefund is equally active in French early-stage and deeptech:
Oktoscience is raising on Sowefund with an AI-enhanced VNS implant for treatment-resistant epilepsy, targeting a €10.7bn neuromodulation market and backed by patents, iLab recognition and JEI tax status (30% income tax reduction).
Losonnante offers a patented bone-conduction audio solution for museums and public spaces, already used by flagship clients such as Mont Saint-Michel, BMW, L’Oréal and JCDecaux – an attractive play on the cultural & creative industries.
Sowefund is also promoting a tax-optimization webinar showing how French investors can reduce up to €50,000 of tax in 30 minutes using IR-PME, JEI/JEIR and live Sowefund campaigns.
In sports-tech, Playse (co-founded with Blaise Matuidi) is live on Sowefund with a SaaS platform democratizing pro-level football training via AI for amateur clubs, 150+ coaches and 8,000+ young players – another flagship deal in a fast-growing niche. โฝ
Invesdor DACH focuses on regulated crowdinvesting for yield-seeking investors:
The standout campaign is Ginolis, a Finnish MedTech automation company for diagnostic systems, offering 9.5% annual interest over 4 years with quarterly payments, backed by a global customer base across 37 countries.
Invesdor DACH is simultaneously running brand-building campaigns debunking “5 myths of crowdinvesting” and Halloween-themed calls to shift capital from low-yield savings to sustainable, high-impact corporate bonds and loans on the platform.
CONDA Capital Group combines sectoral content with active deal promotion:
The team launched an industry-wide survey on financing and digitalisation in tourism & leisure, aiming to inform future crowdinvesting structures for hotels and tourism assets.
Multiple posts invite investors to webinars and pitch events, notably:
A Roatel micro-hotel webinar explaining why modular micro-hotels could be a structural growth theme.
“Let Them Pitch” live event in Vienna, where five companies compete for investor votes, including coinIX (crypto/fintech) and a Best Western hotel project – giving CONDA users curated access to diverse private deals.
A dedicated webinar with Crowd Ukraine Invest AG and GROPYUS, explaining how equity financing can support reconstruction projects in Western Ukraine via real-estate developments, highlighting both impact and return potential.
Companisto continues to act as a major German equity platform for tech and biotech:
Peeriot (Fraunhofer spin-off) has opened its angel round, enabling cloud-less, resilient IoT networks where machines coordinate locally without central servers. Institutional investors such as TGFS and BMT have already committed €1.5m, and retail investors can still join Phase 1 before it closes.
PerioTrap Pharmaceuticals is in Phase 2 of its round, targeting a new treatment for periodontitis that preserves the healthy microbiome, with co-investment by bmp Ventures and entry tickets from €250 – an example of deep biotech crowd-institutional syndication.
Cellbox Solutions raised significant capital from Companisto Angels for its “Warmchain” cell-transport technology, reducing cell death vs classic cold transport, with gamified marketing via a “Neuron Tamagotchi” that lets users simulate keeping cells alive.
Upcoming is UV Energy, converting parking lots into power plants with modular solar carports – a pure-play on decentralised solar infrastructure that will soon go live as a full equity round on Companisto.
Crowdberry (Slovakia/Czech Republic) leans heavily into real estate and growth SMEs:
On the real-estate side, Crowdberry is promoting a fully leased logistics hall near Prague with expected double-digit yields and strong tenant profile, alongside a first credit-type investment into the residential project “Gutovka” in Prague – letting investors co-finance a live development in a high-demand market.
Crowdberry is also hosting large webinars on how to invest in real estate without owning a buy-to-let flat, covering residential markets in Prague and Bratislava, office-to-residential conversions and current yield expectations.
The platform announced “Women & Wealth by Crowdberry”, an event focused on female investors and leaders, featuring former Slovak president Zuzana ฤaputová, signaling a strong ESG and gender-equality positioning.
As taxes and regulation tighten, Crowdberry is rolling out digitally native bonds under the EU DLT Pilot Regime, offering corporate loans and digital bonds for companies like Boataround and Eyerim in CZK and EUR – a big structural platform update for fixed-income-oriented investors.
FunderNation (Germany) keeps building a niche in energy transition and impact:
The platform is promoting an online event “Pioneers of the New Energy World” featuring three portfolio companies: HEIONTEC (power from ambient heat), paXos Solar (integrated solar roofs providing power and heat) and CYTOK (power-to-gas technology turning surplus green electricity into synthetic gas).
Kitepower, a flying-kite wind power company, is showcased at TU Delft’s “Flying Solo” exhibition and on a themed tram between Delft and The Hague – a strong branding push for its live campaign on FunderNation.
FunderNation launched a two-question investor satisfaction survey rewarding participants with investment vouchers, and continues to position HEIONTEC as a core deal targeting decentralised energy security via “autonomous cells”.
Invesdor Nordics brings Nordic tech and impact deals to European investors:
Lynsight is a new MedTech opportunity, offering DiagMMR, a DNA-based test revealing inherited cancer risk years before symptoms appear. Investors can back a company at the intersection of early diagnostics, genetics and preventive healthcare. ๐งฌ
Taito Learning is another fresh listing: an edtech SaaS that turns essential lessons into story-based learning games, already used by 2,000+ schools with over half of revenues coming from the US. The business model is built on annual licenses for schools and districts, operating in a $5–7bn US digital learning market.
Invesdor Nordics also reminds investors that they can start investing in pre-vetted European growth companies from €250, with a growing mix of health, education and sustainability-oriented issuers.
SeedBlink (CEE-based private-markets platform) highlights both new and existing portfolio value:
Voxa, Romania’s leading audio-reading platform with 1M+ users and €5.5m ARR, is returning to SeedBlink with a new round and has been featured in live pitches and announcements; the company is expanding across Southern Europe and LATAM.
SeedBlink’s weekly tech digests flag major European VC news (new funds, mega-rounds for Bending Spoons, EU Scale-up Europe Fund, etc.), situating SeedBlink deals in a broader capital-markets context.
October round-up posts point to momentum across the portfolio – e.g. LANDE securing a €10m EIF guarantee and dotLumen winning GITEX Global – while also promoting secondary deals such as PandaDoc.
Mamacrowd remains a key Italian equity crowdfunding venue:
Breaders – Forno Brisa is back on Mamacrowd with a new funding round. The premium bakery-café group has opened 12 new locations in two years, completed four business integrations in 2024 and targets €21.6m revenues in 2025 (+25% YoY). The group is a B-Corp, Great Place to Work and Gender Equity certified, positioning Breaders as a mix of growth and ESG investing.
WeAreStarting provides transparency on the Italian market and its own performance:
The platform reports having raised €960,000 between Jan 2024 and July 2025 across 8 completed campaigns, with average capital per deal up 6% vs 2023, and top recipients including Spacca (fast casual food), E-dway (e-mobility tourism in Tuscany) and Circular Fiber (upcycling artichoke waste into food products).
A geographic breakdown of Italian equity crowdfunding shows that Lombardy, Emilia-Romagna and Lazio dominate deal origination, while the South remains structurally under-represented – important context for investors seeking regional diversification.
A recent “Autumn crowdfunding” update presents three new campaigns, two already in overfunding, underlining sustained investor appetite on WeAreStarting in Q4. ๐
Doorway continues to position itself as a curated, professional gateway to Italian startups and scale-ups:
Portfolio company Lionhealth is in the spotlight as its CEO, Elena Paola Lanati, is named among Forbes Italy’s 100 top managers, reinforcing the quality of Doorway’s deal selection.
Grooming brand Barberino’s, another Doorway portfolio company, has been chosen for the Ulta Beauty Marketplace in the US, giving it access to 1,400+ stores and 44m loyalty customers – a strong internationalisation milestone.
Doorway also announced a positive EUROCROWD compliance review, confirming high standards of transparency and investor communication under the ECSPR regime.
Finally, Doorway is a partner of the new Business Angel Summit 2025 in Milan, where its CEO and CRO speak on venture capital and why to invest in startups now – signalling the platform’s central role in Italian angel and VC ecosystems.
Startupxplore (Spain) showcases a strong impact-health deal:
Opportunity Health is raising funds on Startupxplore for Yarnasa, an automatic anti-choking device aimed at tackling 3,500 choking deaths per year in Spain (≈10 per day), with European patent pending and CE marking in preparation.
The deal offers up to 50% IRPF tax deduction for retail investors, with a B2B renting model targeting nursing homes, socio-health centres, restaurants, transport and emergency services – highlighting both high social impact and a clear commercial model.
Crowdcube reinforces its leadership in European private markets:
The platform announced a major milestone: 2 million registered investors, confirming Crowdcube as the largest distributor of private-market investments to retail investors across the UK and EU.
Recent posts highlight an extremely active primary pipeline, including:
Playtomic, the world’s leading racket-sports platform, now live on Crowdcube with €346m in annual transactions (+51%), €29m net revenue (+38%), 4.7m players in 66 countries and ~50 new clubs added weekly, after already raising €110m+ from institutional backers.
Weekly “new opportunities” collections featuring companies such as Cornish Lithium, Pearlstone Energy, Jiva Materials (Soluboard®), Stratiphy, un:hurd music, Investa, Gait Shoes, getDilly, SKYTED, Demmi, Flogo Life, QSXL, Plank Hardware and O-Innovations – covering green tech, fintech, HR-tech, consumer brands and AI tools.
Crowdcube Live Paris, held literally on a padel court, showcased Playtomic, La Vie™ and Footbar in front of a community of investors, reinforcing the platform’s event-led, community-driven fundraising strategy. ๐พ
Republic & Republic Europe expand into sports, secondary markets and cultural assets:
Republic is hosting a live AMA on sports investing with its Head of Sports Investment, discussing fan ownership, deal sourcing and the future of sports assets as an alternative investment class.
Republic Europe continues to grow its Secondary Market, with October figures showing £585k+ transacted and 1,067+ share lots traded, with names like Rheal, Heights, Fussy, Fantasy Football Hub and AKT London among the most active.
A new “rTTOK Mirror Note” lets UK investors gain economic exposure to ByteDance (TikTok) from as little as £20, explicitly framed as “culture is the new alpha”.
Community-driven events like “No Strings Attached 2” (no panels, no pitches, just founders networking) and support for Women’s Entrepreneurship Day in Copenhagen underline Republic Europe’s focus on ecosystem building and gender equality in startup funding.
Capital Cell remains a specialist in European life-science equity:
Active campaigns include FreeOx Biotech (stroke therapy Ox-01), SOQUT Imaging (digital liver biopsy by MRI for MASH), Axoltis Pharma (Phase 2 drug candidate for ALS and neurodegenerative diseases), ALA Diagnostics (first blood-based early diagnosis kit for multiple sclerosis), Batea Oncology (GlioHook device for glioblastoma) and autonomyo (robotic rehab to cut post-stroke disability by 50%).
Campaign status updates show multiple rounds approaching or surpassing their targets, with Batea Oncology reaching its maximum €750k overfunding cap shortly before closing, and Axoltis Pharma constrained by an overfunding limit after strong institutional participation.
A separate highlight is ALA Diagnostics’ lead investor BeAble Capital committing €1m, strengthening the case for crowd investors by adding deep technical and financial due diligence.
Most recently, Capital Cell introduced a new opportunity: Alaya.bio, working on in vivo CAR-T therapies that could make cell therapies “50x cheaper, faster and more accessible” by reprogramming immune cells directly in the patient, instead of in expensive ex-vivo labs.
Spreds (Belgium) offers a blend of direct deals and fund-type products:
DPT Antwerp – Diamanti Per Tutti taps into the affordable-luxury jewellery segment, targeting €10m+ revenue and €1.5–2m EBITDA by 2030, with a clear exit strategy (Series C or acquisition by a major fashion/jewellery group) and potential 2–5x investor return.
Newtree Impact gives retail investors exposure to an institutional-grade impact VC portfolio of 90+ companies across 13 countries, plus liquidity via an Euronext Access listing.
La Spiruline de Gaume (LD4) is raising to scale its local, low-impact spirulina farm, positioned as a sustainable superfood, with the campaign in its final days.
Presscuff, a patented endotracheal tube with double cuff system to avoid ventilation-associated pneumonia, relaunched its fundraising after strong initial traction (€135k in two weeks).
Spreds also promotes its Tracer Tax Shelter product, automating diversified investments into Belgian startups while enabling up to 45% tax reduction for eligible investors.
Dozen Investments (Spain) is leaning into content-driven investor education: multiple newsletters and the “Guide 2026: Invest with Criteria in the New Cycle” explain new venture capital dynamics, highlight companies like STAMP, REVER (YC S22), Mabrian Technologies and Amadix, and help investors interpret market signals as VC activity grows ~15% YTD.
Invesdor (Nordics + DACH) and FunderNation complement their pipelines with themed newsletters and campaigns showing how inflation-eroded savings can be redirected into pre-vetted European SMEs, green projects and energy tech.
WeAreStarting adds thought-leadership on R&D spending and equity crowdfunding’s geographic disparities in Italy, reinforcing its positioning as both a platform and a data provider on the local market.
Across Tudigo, Sowefund, Mamacrowd, Doorway, WeAreStarting, CONDA Capital Group, Invesdor,Companisto, Crowdberry, FunderNation, SeedBlink , Startupxplore, Crowdcube, Republic, Capital Cell , Spreds and others, European equity crowdfunding and crowdinvesting platforms are clearly entering a busy end-of-year cycle:
Many new campaigns in MedTech, biotech, energy transition, real estate, consumer brands and sports-tech.
Platform upgrades (UX redesigns, digital bonds under DLT, secondary markets, tax-shelter products) that directly shape investor experience.
Strong overfunding and closing rounds, signaling robust retail demand despite macro uncertainty.
As always, these are high-risk, illiquid investments. Diversification, careful reading of each KIIS / key information document, and alignment with your personal risk profile remain essential. But for investors looking for early-stage growth, impact projects and yield-oriented crowdinvesting, Europe’s platforms are offering a richer menu than ever. ๐๐ก